New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 11, 2012
07:04 EDTPTX, SOMXPernix Therapeutics acquires Somaxon for $25M
Pernix Therapeutics (PTX) and Somaxon Pharmaceuticals (SOMX) announced that they have entered into a definitive merger agreement for Pernix to acquire Somaxon in a stock-for-stock transaction with a total equity value of $25M. Under the terms of the agreement, which has been unanimously approved by the boards of directors of both companies, Somaxon stockholders will receive aggregate consideration equal to $25M in Pernix common stock. The number of shares of Pernix common stock to be issued to the stockholders of Somaxon will be based on the volume-weighted average price of Pernix's common stock over the 30 day period ending on the day immediately prior to the closing of the proposed merger, subject to limitations on the maximum and minimum number of shares of Pernix common stock issuable in the transaction based on a price range of $6.00-$9.00 per share.
News For PTX;SOMX From The Last 14 Days
Check below for free stories on PTX;SOMX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 20, 2014
08:30 EDTPTXPernix closes acquisition of Treximet
Subscribe for More Information
08:29 EDTPTXPernix Therapeutics to host conference call
Conference call to discuss acquisition of Treximet will be held on August 20 at 9 am. Webcast Link
08:24 EDTPTXPernix Therapeutics management to meet with Needham
Subscribe for More Information
08:08 EDTPTXPernix sees FY15 revenue approximately $230M, consensus $214.07M
Sees FY15 adjusted EBITDA $95M.
08:07 EDTPTXPernix Therapeutics sees FY14 revenue $110M-$120M, consensus $116.87M
Subscribe for More Information
08:04 EDTPTXPOZEN announces U.S. rights for Treximet acquired by Pernix Therapeutics
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use